Aman B. Patel, MD is a neurosurgeon at Massachusetts General Hospital specializing in the treatment of vascular disorders of the brain and spine, including cerebral aneurysms, vascular malformations and stroke. He is the director of Cerebrovascular and Endovascular Neurosurgery and co-director of the Neuroendovascular Program, leading a multidisciplinary group focused on cerebrovascular treatments.
Dr. received his medical degree from University of California, Los Angeles (UCLA) and completed his residency at UCLA Medical Center, where he also was a fellow in the Interventional Neuroradiology program. Dr. Patel was recently at Mount Sinai School of Medicine where he served as Full Professor of Neurosurgery and Radiology, director Cerebrovascular and Endovascular Neurosurgery, co-director of the Stroke Program, vice-chairman Department of Neurosurgery and Program Director of the Neurosurgery Residency Program.
Dr. Patel has served on committees of several national organizations, including the Joint Cerebrovascular Section, American Heart Association (AHA), International Stroke Conference, American Association of Neurological Surgeons, Congress Neurological Surgeons and Society of Neuro-Interventional Surgeons. He was a member of the AHA writing group that established guidelines for the treatment of patients with subarachnoid hemorrhage. He has published on topics related cerebral aneurysms, vascular malformations and stroke, and presents internationally on these areas.
Departments, Centers, & Programs:
Clinical Interests:
Treats:
Languages:
Mass General Neurosurgery
55 Fruit St.
Wang Ambulatory Care Center
Suite 745
Boston, MA 02114
Phone: 617-726-3303
Fax: 617-726-7501
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Patel's research interests focus on the endovascular treatment of stroke, carotid and intra-arterial stents, cerebral aneurysm treatment, aneurysm morphology and flow dynamics, and hemorrhagic stroke treatment.
He is involved in multiple National Institutes of Health (NIH) and industry sponsored multi-center studies that investigate treatments related to ischemic stroke, hemorrhagic stroke, new devices and new techniques. He was an early investigator in the initial post-market evaluation of carotid artery stenting (SAPPHIRE) and in the first study on the endovascular treatment of intracranial atherosclerotic stenosis (SAMMPRIS). Some of his active studies include: the Penumbra Liberty trial investigating a new stent device for the treatment of cerebral aneurysms and an NIH trial site studying the surgical treatment of cerebral hemorrhage.
He also actively maintains a clinical database evaluating clinical outcomes and treatments. This database has led to multiple peer reviewed publications.
